Menu
Menu
Hoogman M, van Rooij D, Klein M, Boedhoe P, Ilioska I, Li T, Patel Y, Postema MC, Zhang-James Y, Anagnostou E, Arango C, Auzias G, Banaschewski T, Bau CHD, Behrmann M, Bellgrove MA, Brandeis D, Brem S, Busatto GF, Calderoni S, Calvo R, Castellanos FX, Coghill D, Conzelmann A, Daly E, Deruelle C, Dinstein I, Durston S, Ecker C, Ehrlich S, Epstein JN, Fair DA, Fitzgerald J, Freitag CM, Frodl T, Gallagher L, Grevet EH, Haavik J, Hoekstra PJ, Janssen J, Karkashadze G, King JA, Konrad K, Kuntsi J, Lazaro L, Lerch JP, Lesch KP, Louza MR, Luna B, Mattos P, McGrath J, Muratori F, Murphy C, Nigg JT, Oberwelland-Weiss E, O’Gorman Tuura RL, O’Hearn K, Oosterlaan J, Parellada M, Pauli P, Plessen KJ, Ramos-Quiroga JA, Reif A, Reneman L, Retico A, Rosa PGP, Rubia K, Shaw P, Silk TJ, Tamm L, Vilarroya O, Walitza S, Jahanshad N, Faraone SV, Francks C, van den Heuvel OA, Paus T, Thompson PM, Buitelaar JK, Franke B. Consortium neuroscience of attention deficit/hyperactivity disorder and autism spectrum disorder: The ENIGMA adventure. 2022 Hum Brain Mapp. J43(1):37-55.
Kaiser A, Reneman L, Lucassen PJ, de Vries TJ, Schrantee A, Kaag AM. Targeting working memory to modify emotional reactivity in adult attention deficit hyperactivity disorder: a functional magnetic resonance imaging study. Brain Imaging Behav. 2022 Apr;16(2):680-691.
Kaiser A, Reneman L, Solleveld MM, Coolen BF, Scherder EJA, Knutsson L, Bjørnerud A, van Osch MJP, Wijnen JP, Lucassen PJ, Schrantee A. A Randomized Controlled Trial on the Effects of a 12-Week High- vs. Low-Intensity Exercise Intervention on Hippocampal Structure and Function in Healthy, Young Adults. Front Psychiatry. 2022 Jan 21;12:780095.
Batelaan NM, Seldenrijk A, van den Heuvel OA, van Balkom AJLM, Kaiser A, Reneman L, Tan HL. Anxiety, Mental Stress, and Sudden Cardiac Arrest: Epidemiology, Possible Mechanisms and Future Research. Front Psychiatry. 2022 Feb 3;12:813518.
Kaiser A, Broeder C, Cohen JR, Douw L, Reneman L, Schrantee A. Effects of a single-dose methylphenidate challenge on resting-state functional connectivity in stimulant-treatment naive children and adults with ADHD. Hum Brain Mapp. 2022 Jul 4. doi: 10.1002/hbm.25981.
Li T, van Rooij D, Roth Mota N, Buitelaar JK; ENIGMA ADHD Working Group, Hoogman M, Arias Vasquez A, Franke B. Characterizing neuroanatomic heterogeneity in people with and without ADHD based on subcortical brain volumes. J Child Psychol Psychiatry. 2021 Sep;62(9):1140-1149.
Tahmasian M, Aleman A, Andreassen OA, Arab Z, Baillet M, Benedetti F, Bresser T, Bright J, Chee MWL, Chylinski D, Cheng W, Deantoni M, Dresler M, Eickhoff SB, Eickhoff CR, Elvsåshagen T, Feng J, Foster-Dingley JC, Ganjgahi H, Grabe HJ, Groenewold NA, Ho TC, Bong Hong S, Houenou J, Irungu B, Jahanshad N, Khazaie H, Kim H, Koshmanova E, Kocevska D, Kochunov P, Lakbila-Kamal O, Leerssen J, Li M, Luik AI, Muto V, Narbutas J, Nilsonne G, O’Callaghan VS, Olsen A, Osorio RS, Poletti S, Poudel G, Reesen JE, Reneman L, Reyt M, Riemann D, Rosenzweig I, Rostampour M, Saberi A, Schiel J, Schmidt C, Schrantee A, Sciberras E, Silk TJ, Sim K, Smevik H, Soares JC, Spiegelhalder K, Stein DJ, Talwar P, Tamm S, Teresi GL, Valk SL, Van Someren E, Vandewalle G, Van Egroo M, Völzke H, Walter M, Wassing R, Weber FD, Weihs A, Westlye LT, Wright MJ, Wu MJ, Zak N, Zarei M. ENIGMA-Sleep: Challenges, opportunities, and the road map. J Sleep Res. 2021 Dec;30(6):e13347.
Reneman L, van der Pluijm M, Schrantee A, van de Giessen E. Imaging of the dopamine system with focus on pharmacological MRI and neuromelanin imaging. Eur J Radiol. 2021 Jul;140:109752.
de Vries RJ, Jaeger B, Hellebrekers DMEI, Reneman L, Verhamme C, Smeets HJM, van Maarle MC, de Visser M, Bleeker FE. Distal muscle weakness and optic atrophy without central nervous system involvement in a patient with a homozygous missense mutation in the C19ORF12-gene. Clin Neurol Neurosurg. 2021 Jul;206:106637.
Derksen M, Rhemrev V, van der Veer M, Jolink L, Zuidinga B, Mulder T, Reneman L, Nederveen A, Feenstra M, Willuhn I, Denys D. Animal studies in clinical MRI scanners: A custom setup for combined fMRI and deep-brain stimulation in awake rats. J Neurosci Methods. 2021 Aug 1;360:109240.
Campos AI, Thompson PM, Veltman DJ, Pozzi E, van Veltzen LS, Jahanshad N, Adams MJ, Baune BT, Berger K, Brosch K, Bülow R, Connolly CG, Dannlowski U, Davey CG, de Zubicaray GI, Dima D, Erwin-Grabner T, Evans JW, Fu CHY, Gotlib IH, Goya-Maldonado R, Grabe HJ, Grotegerd D, Harris MA, Harrison BJ, Hatton SN, Hermesdorf M, Hickie IB, Ho TC, Kircher T, Krug A, Lagopoulos J, Lemke H, McMahon K, MacMaster FP, Martin NG, McIntosh AM, Medland SE, Meinert S, Meller T, Nenadic I, Opel N, Redlich R, Reneman L, Repple J, Sacchet MD, Schmitt S, Schrantee A, Sim K, Singh A, Stein F, Strike LT, van der Wee NJA, van der Werff SJA, Völzke H, Waltemate L, Whalley HC, Wittfeld K, Wright MJ, Yang TT, Zarate CA, Schmaal L, Rentería ME; ENIGMA-MDD Working Group. Brain Correlates of Suicide Attempt in 18,925 Participants Across 18 International Cohorts. Biol Psychiatry. 2021 Aug 15;90(4):243-252.
de Ruiter MB, Reneman L, Kieffer JM, Oldenburg HSA, Schagen SB. Brain White Matter Microstructure as a Risk Factor for Cognitive Decline After Chemotherapy for Breast Cancer. J Clin Oncol. 2021 Dec 10;39(35):3908-3917.
Postema MC, Hoogman M, Ambrosino S, Asherson P, Banaschewski T, Bandeira CE, Baranov A, Bau CHD, Baumeister S, Baur-Streubel R, Bellgrove MA, Biederman J, Bralten J, Brandeis D, Brem S, Buitelaar JK, Busatto GF, Castellanos FX, Cercignani M, Chaim-Avancini TM, Chantiluke KC, Christakou A, Coghill D, Conzelmann A, Cubillo AI, Cupertino RB, de Zeeuw P, Doyle AE, Durston S, Earl EA, Epstein JN, Ethofer T, Fair DA, Fallgatter AJ, Faraone SV, Frodl T, Gabel MC, Gogberashvili T, Grevet EH, Haavik J, Harrison NA, Hartman CA, Heslenfeld DJ, Hoekstra PJ, Hohmann S, Høvik MF, Jernigan TL, Kardatzki B, Karkashadze G, Kelly C, Kohls G, Konrad K, Kuntsi J, Lazaro L, Lera-Miguel S, Lesch KP, Louza MR, Lundervold AJ, Malpas CB, Mattos P, McCarthy H, Namazova-Baranova L, Nicolau R, Nigg JT, Novotny SE, Oberwelland Weiss E, O’Gorman Tuura RL, Oosterlaan J, Oranje B, Paloyelis Y, Pauli P, Picon FA, Plessen KJ, Ramos-Quiroga JA, Reif A, Reneman L, Rosa PGP, Rubia K, Schrantee A, Schweren LJS, Seitz J, Shaw P, Silk TJ, Skokauskas N, Soliva Vila JC, Stevens MC, Sudre G, Tamm L, Tovar-Moll F, van Erp TGM, Vance A, Vilarroya O, Vives-Gilabert Y, von Polier GG, Walitza S, Yoncheva YN, Zanetti MV, Ziegler GC, Glahn DC, Jahanshad N, Medland SE, Thompson PM, Fisher SE, Franke B, Francks C. 2021. Analysis of structural brain asymmetries in attention-deficit/hyperactivity disorder in 39 datasets. J Child Psychol Psychiatry (in press).
Tamminga HGH, Reneman L, Schrantee A, Bottelier MA, Bouziane C, Geurts HM, Groenman AP. 2021. Do effects of methylphenidate on cognitive performance last beyond treatment? A randomized placebo-controlled trial in boys and men with ADHD. Eur Neuropsychopharmacol. 46:1-13.
Zhang-James Y, Helminen EC, Liu J; ENIGMA-ADHD Working Group, Franke B, Hoogman M, Faraone SV. 2021. Evidence for similar structural brain anomalies in youth and adult attention-deficit/hyperactivity disorder: a machine learning analysis. Transl Psychiatry. 11:82.
Solleveld MM, Schrantee A, Homberg JR, Lucassen PJ, Reneman L. 2020. The influence of age-of-onset of antidepressant use on the acute CBF response to a citalopram challenge; a pharmacological MRI study. Psychiatry Res Neuroimaging. 2020 Sep 30;303:111126.
Mzayek Y, de Ruiter MB, Oldenburg HSA, Reneman L, Schagen SB. 2020. Measuring decline in white matter integrity after systemic treatment for breast cancer: omitting skeletonization enhances sensitivity. Brain Imaging Behav. 2020 Jul 23. doi: 10.1007/s11682-020-00319-1. Online ahead of print.
Patel Y, Parker N, Shin J, Howard D, French L, Thomopoulos SI, Pozzi E, Abe Y, Abé C, Anticevic A, Alda M, Aleman A, Alloza C, Alonso-Lana S, Ameis SH, Anagnostou E, McIntosh AA, Arango C, Arnold PD, Asherson P, Assogna F, Auzias G, Ayesa-Arriola R, Bakker G, Banaj N, Banaschewski T, Bandeira CE, Baranov A, Bargalló N, Bau CHD, Baumeister S, Baune BT, Bellgrove MA, Benedetti F, Bertolino A, Boedhoe PSW, Boks M, Bollettini I, Del Mar Bonnin C, Borgers T, Borgwardt S, Brandeis D, Brennan BP, Bruggemann JM, Bülow R, Busatto GF, Calderoni S, Calhoun VD, Calvo R, Canales-Rodríguez EJ, Cannon DM, Carr VJ, Cascella N, Cercignani M, Chaim-Avancini TM, Christakou A, Coghill D, Conzelmann A, Crespo-Facorro B, Cubillo AI, Cullen KR, Cupertino RB, Daly E, Dannlowski U, Davey CG, Denys D, Deruelle C, Di Giorgio A, Dickie EW, Dima D, Dohm K, Ehrlich S, Ely BA, Erwin-Grabner T, Ethofer T, Fair DA, Fallgatter AJ, Faraone SV, Fatjó-Vilas M, Fedor JM, Fitzgerald KD, Ford JM, Frodl T, Fu CHY, Fullerton JM, Gabel MC, Glahn DC, Roberts G, Gogberashvili T, Goikolea JM, Gotlib IH, Goya-Maldonado R, Grabe HJ, Green MJ, Grevet EH, Groenewold NA, Grotegerd D, Gruber O, Gruner P, Guerrero-Pedraza A, Gur RE, Gur RC, Haar S, Haarman BCM, Haavik J, Hahn T, Hajek T, Harrison BJ, Harrison NA, Hartman CA, Whalley HC, Heslenfeld DJ, Hibar DP, Hilland E, Hirano Y, Ho TC, Hoekstra PJ, Hoekstra L, Hohmann S, Hong LE, Höschl C, Høvik MF, Howells FM, Nenadic I, Jalbrzikowski M, James AC, Janssen J, Jaspers-Fayer F, Xu J, Jonassen R, Karkashadze G, King JA, Kircher T, Kirschner M, Koch K, Kochunov P, Kohls G, Konrad K, Krämer B, Krug A, Kuntsi J, Kwon JS, Landén M, Landrø NI, Lazaro L, Lebedeva IS, Leehr EJ, Lera-Miguel S, Lesch KP, Lochner C, Louza MR, Luna B, Lundervold AJ, MacMaster FP, Maglanoc LA, Malpas CB, Portella MJ, Marsh R, Martyn FM, Mataix-Cols D, Mathalon DH, McCarthy H, McDonald C, McPhilemey G, Meinert S, Menchón JM, Minuzzi L, Mitchell PB, Moreno C, Morgado P, Muratori F, Murphy CM, Murphy D, Mwangi B, Nabulsi L, Nakagawa A, Nakamae T, Namazova L, Narayanaswamy J, Jahanshad N, Nguyen DD, Nicolau R, O’Gorman Tuura RL, O’Hearn K, Oosterlaan J, Opel N, Ophoff RA, Oranje B, García de la Foz VO, Overs BJ, Paloyelis Y, Pantelis C, Parellada M, Pauli P, Picó-Pérez M, Picon FA, Piras F, Piras F, Plessen KJ, Pomarol-Clotet E, Preda A, Puig O, Quidé Y, Radua J, Ramos-Quiroga JA, Rasser PE, Rauer L, Reddy J, Redlich R, Reif A, Reneman L, Repple J, Retico A, Richarte V, Richter A, Rosa PGP, Rubia KK, Hashimoto R, Sacchet MD, Salvador R, Santonja J, Sarink K, Sarró S, Satterthwaite TD, Sawa A, Schall U, Schofield PR, Schrantee A, Seitz J, Serpa MH, Setién-Suero E, Shaw P, Shook D, Silk TJ, Sim K, Simon S, Simpson HB, Singh A, Skoch A, Skokauskas N, Soares JC, Soreni N, Soriano-Mas C, Spalletta G, Spaniel F, Lawrie SM, Stern ER, Stewart SE, Takayanagi Y, Temmingh HS, Tolin DF, Tomecek D, Tordesillas-Gutiérrez D, Tosetti M, Uhlmann A, van Amelsvoort T, van der Wee NJA, van der Werff SJA, van Haren NEM, van Wingen GA, Vance A, Vázquez-Bourgon J, Vecchio D, Venkatasubramanian G, Vieta E, Vilarroya O, Vives-Gilabert Y, Voineskos AN, Völzke H, von Polier GG, Walton E, Weickert TW, Weickert CS, Weideman AS, Wittfeld K, Wolf DH, Wu MJ, Yang TT, Yang K, Yoncheva Y, Yun JY, Cheng Y, Zanetti MV, Ziegler GC, Franke B, Hoogman M, Buitelaar JK, van Rooij D, Andreassen OA, Ching CRK, Veltman DJ, Schmaal L, Stein DJ, van den Heuvel OA, Turner JA, van Erp TGM, Pausova Z, Thompson PM, Paus T. Virtual van Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders. 2020. JAMA Psychiatry. Aug 26:e202694. doi: 10.1001/jamapsychiatry.2020.2694.
Dijk T, Barth P, Baas F, Reneman L, Poll-The BT. 2020. Postnatal Brain Growth Patterns in Pontocerebellar Hypoplasia. Neuropediatrics. 2020 Oct 27. doi: 10.1055/s-0040-1716900.
Boedhoe PSW, van Rooij D, Hoogman M, Twisk JWR, Schmaal L, Abe Y, Alonso P, Ameis SH, Anikin A, Anticevic A, Arango C, Arnold PD, Asherson P, Assogna F, Auzias G, Banaschewski T, Baranov A, Batistuzzo MC, Baumeister S, Baur-Streubel R, Behrmann M, Bellgrove MA, Benedetti F, Beucke JC, Biederman J, Bollettini I, Bose A, Bralten J, Bramati IE, Brandeis D, Brem S, Brennan BP, Busatto GF, Calderoni S, Calvo A, Calvo R, Castellanos FX, Cercignani M, Chaim-Avancini TM, Chantiluke KC, Cheng Y, Cho KIK, Christakou A, Coghill D, Conzelmann A, Cubillo AI, Dale AM, Dallaspezia S, Daly E, Denys D, Deruelle C, Di Martino A, Dinstein I, Doyle AE, Durston S, Earl EA, Ecker C, Ehrlich S, Ely BA, Epstein JN, Ethofer T, Fair DA, Fallgatter AJ, Faraone SV, Fedor J, Feng X, Feusner JD, Fitzgerald J, Fitzgerald KD, Fouche JP, Freitag CM, Fridgeirsson EA, Frodl T, Gabel MC, Gallagher L, Gogberashvili T, Gori I, Gruner P, Gürsel DA, Haar S, Haavik J, Hall GB, Harrison NA, Hartman CA, Heslenfeld DJ, Hirano Y, Hoekstra PJ, Hoexter MQ, Hohmann S, Høvik MF, Hu H, Huyser C, Jahanshad N, Jalbrzikowski M, James A, Janssen J, Jaspers-Fayer F, Jernigan TL, Kapilushniy D, Kardatzki B, Karkashadze G, Kathmann N, Kaufmann C, Kelly C, Khadka S, King JA, Koch K, Kohls G, Kohls K, Kuno M, Kuntsi J, Kvale G, Kwon JS, Lázaro L, Lera-Miguel S, Lesch KP, Hoekstra L, Liu Y, Lochner C, Louza MR, Luna B, Lundervold AJ, Malpas CB, Marques P, Marsh R, Martínez-Zalacaín I, Mataix-Cols D, Mattos P, McCarthy H, McGrath J, Mehta MA, Menchón JM, Mennes M, Martinho MM, Moreira PS, Morer A, Morgado P, Muratori F, Murphy CM, Murphy DGM, Nakagawa A, Nakamae T, Nakao T, Namazova-Baranova L, Narayanaswamy JC, Nicolau R, Nigg JT, Novotny SE, Nurmi EL, Weiss EO, O’Gorman Tuura RL, O’Hearn K, O’Neill J, Oosterlaan J, Oranje B, Paloyelis Y, Parellada M, Pauli P, Perriello C, Piacentini J, Piras F, Piras F, Plessen KJ, Puig O, Ramos-Quiroga JA, Reddy YCJ, Reif A, Reneman L, Retico A, Rosa PGP, Rubia K, Rus OG, Sakai Y, Schrantee A, Schwarz L, Schweren LJS, Seitz J, Shaw P, Shook D, Silk TJ, Simpson HB, Skokauskas N, Soliva Vila JC, Solovieva A, Soreni N, Soriano-Mas C, Spalletta G, Stern ER, Stevens MC, Stewart SE, Sudre G, Szeszko PR, Tamm L, Taylor MJ, Tolin DF, Tosetti M, Tovar-Moll F, Tsuchiyagaito A, van Erp TGM, van Wingen GA, Vance A, Venkatasubramanian G, Vilarroya O, Vives-Gilabert Y, von Polier GG, Walitza S, Wallace GL, Wang Z, Wolfers T, Yoncheva YN, Yun JY, Zanetti MV, Zhou F, Ziegler GC, Zierhut KC, Zwiers MP; ENIGMA ADHD working group; ENIGMA ASD working group; ENIGMA OCD working group, Thompson PM, Stein DJ, Buitelaar J, Franke B, van den Heuvel OA. Subcortical Brain Volume, Regional Cortical Thickness, and Cortical Surface Area Across Disorders: Findings From the ENIGMA ADHD, ASD, and OCD Working Groups.Am J Psychiatry. 2020 Jun 16:appiajp202019030331 (in press).
Mutsaerts HJMM, Petr J, Groot P, Vandemaele P, Ingala S, Robertson AD, Václavů L, Groote I, Kuijf H, Zelaya F, O’Daly O, Hilal S, Wink AM, Kant I, Caan MWA, Morgan C, de Bresser J, Lysvik E, Schrantee A, Bjørnebekk A, Clement P, Shirzadi Z, Kuijer JPA, Wottschel V, Anazodo UC, Pajkrt D, Richard E, Bokkers RPH, Reneman L, Masellis M, Günther M, MacIntosh BJ, Achten E, Chappell MA, van Osch MJP, Golay X, Thomas DL, de Vita E, Bjørnerud A, Nederveen A, Hendrikse J, Asllani I, Barkhof F. ExploreASL: an image processing pipeline for multi-center ASL perfusion MRI studies. Neuroimage. 2020 Jun 8:117031. doi: 10.1016/j.neuroimage.2020.117031.
Schmaal L, Pozzi E, C Ho T, van Velzen LS, Veer IM, Opel N, Van Someren EJW, Han LKM, Aftanas L, Aleman A, Baune BT, Berger K, Blanken TF, Capitão L, Couvy-Duchesne B, R Cullen K, Dannlowski U, Davey C, Erwin-Grabner T, Evans J, Frodl T, Fu CHY, Godlewska B, Gotlib IH, Goya-Maldonado R, Grabe HJ, Groenewold NA, Grotegerd D, Gruber O, Gutman BA, Hall GB, Harrison BJ, Hatton SN, Hermesdorf M, Hickie IB, Hilland E, Irungu B, Jonassen R, Kelly S, Kircher T, Klimes-Dougan B, Krug A, Landrø NI, Lagopoulos J, Leerssen J, Li M, Linden DEJ, MacMaster FP, M McIntosh A, Mehler DMA, Nenadić I, Penninx BWJH, Portella MJ, Reneman L, Rentería ME, Sacchet MD, G Sämann P, Schrantee A, Sim K, Soares JC, Stein DJ, Tozzi L, van Der Wee NJA, van Tol MJ, Vermeiren R, Vives-Gilabert Y, Walter H, Walter M, Whalley HC, Wittfeld K, Whittle S, Wright MJ, Yang TT, Zarate C Jr, Thomopoulos SI, Jahanshad N, Thompson PM, Veltman DJ. ENIGMA MDD: seven years of global neuroimaging studies of major depression through worldwide data sharing. Transl Psychiatry. 2020 May 29;10(1):172. doi: 10.1038/s41398-020-0842-6.
Opel N, Thalamuthu A, Milaneschi Y, Grotegerd D, Flint C, Leenings R, Goltermann J, Richter M, Hahn T, Woditsch G, Berger K, Hermesdorf M, McIntosh A, Whalley HC, Harris MA, MacMaster FP, Walter H, Veer IM, Frodl T, Carballedo A, Krug A, Nenadic I, Kircher T, Aleman A, Groenewold NA, Stein DJ, Soares JC, Zunta-Soares GB, Mwangi B, Wu MJ, Walter M, Li M, Harrison BJ, Davey CG, Cullen KR, Klimes-Dougan B, Mueller BA, Sämann PG, Penninx B, Nawijn L, Veltman DJ, Aftanas L, Brak IV, Filimonova EA, Osipov EA, Reneman L, Schrantee A, Grabe HJ, Van der Auwera S, Wittfeld K, Hosten N, Völzke H, Sim K, Gotlib IH, Sacchet MD, Lagopoulos J, Hatton SN, Hickie I, Pozzi E, Thompson PM, Jahanshad N, Schmaal L, Baune BT, Dannlowski U. Brain structural abnormalities in obesity: relation to age, genetic risk, and common psychiatric disorders : Evidence through univariate and multivariate mega-analysis including 6420 participants from the ENIGMA MDD working group. Mol Psychiatry. 2020 May 28. doi: 10.1038/s41380-020-0774-9.
Han LKM, Dinga R, Hahn T, Ching CRK, Eyler LT, Aftanas L, Aghajani M, Aleman A, Baune BT, Berger K, Brak I, Filho GB, Carballedo A, Connolly CG, Couvy-Duchesne B, Cullen KR, Dannlowski U, Davey CG, Dima D, Duran FLS, Enneking V, Filimonova E, Frenzel S, Frodl T, Fu CHY, Godlewska BR, Gotlib IH, Grabe HJ, Groenewold NA, Grotegerd D, Gruber O, Hall GB, Harrison BJ, Hatton SN, Hermesdorf M, Hickie IB, Ho TC, Hosten N, Jansen A, Kähler C, Kircher T, Klimes-Dougan B, Krämer B, Krug A, Lagopoulos J, Leenings R, MacMaster FP, MacQueen G, McIntosh A, McLellan Q, McMahon KL, Medland SE, Mueller BA, Mwangi B, Osipov E, Portella MJ, Pozzi E, Reneman L, Repple J, Rosa PGP, Sacchet MD, Sämann PG, Schnell K, Schrantee A, Simulionyte E, Soares JC, Sommer J, Stein DJ, Steinsträter O, Strike LT, Thomopoulos SI, van Tol MJ, Veer IM, Vermeiren RRJM, Walter H, van der Wee NJA, van der Werff SJA, Whalley H, Winter NR, Wittfeld K, Wright MJ, Wu MJ, Völzke H, Yang TT, Zannias V, de Zubicaray GI, Zunta-Soares GB, Abé C, Alda M, Andreassen OA, Bøen E, Bonnin CM, Canales-Rodriguez EJ, Cannon D, Caseras X, Chaim-Avancini TM, Elvsåshagen T, Favre P, Foley SF, Fullerton JM, Goikolea JM, Haarman BCM, Hajek T, Henry C, Houenou J, Howells FM, Ingvar M, Kuplicki R, Lafer B, Landén M, Machado-Vieira R, Malt UF, McDonald C, Mitchell PB, Nabulsi L, Otaduy MCG, Overs BJ, Polosan M, Pomarol-Clotet E, Radua J, Rive MM, Roberts G, Ruhe HG, Salvador R, Sarró S, Satterthwaite TD, Savitz J, Schene AH, Schofield PR, Serpa MH, Sim K, Soeiro-de-Souza MG, Sutherland AN, Temmingh HS, Timmons GM, Uhlmann A, Vieta E, Wolf DH, Zanetti MV, Jahanshad N, Thompson PM, Veltman DJ, Penninx BWJH, Marquand AF, Cole JH, Schmaal L. Brain aging in major depressive disorder: results from the ENIGMA major depressive disorder working group. Mol Psychiatry. 2020 May 18. doi: 10.1038/s41380-020-0754-0.
Hoogman M, van Rooij D, Klein M, Boedhoe P, Ilioska I, Li T, Patel Y, Postema MC, Zhang-James Y, Anagnostou E, Arango C, Auzias G, Banaschewski T, Bau CHD, Behrmann M, Bellgrove MA, Brandeis D, Brem S, Busatto GF, Calderoni S, Calvo R, Castellanos FX, Coghill D, Conzelmann A, Daly E, Deruelle C, Dinstein I, Durston S, Ecker C, Ehrlich S, Epstein JN, Fair DA, Fitzgerald J, Freitag CM, Frodl T, Gallagher L, Grevet EH, Haavik J, Hoekstra PJ, Janssen J, Karkashadze G, King JA, Konrad K, Kuntsi J, Lazaro L, Lerch JP, Lesch KP, Louza MR, Luna B, Mattos P, McGrath J, Muratori F, Murphy C, Nigg JT, Oberwelland-Weiss E, O’Gorman Tuura RL, O’Hearn K, Oosterlaan J, Parellada M, Pauli P, Plessen KJ, Ramos-Quiroga JA, Reif A, Reneman L, Retico A, Rosa PGP, Rubia K, Shaw P, Silk TJ, Tamm L, Vilarroya O, Walitza S, Jahanshad N, Faraone SV, Francks C, van den Heuvel OA, Paus T, Thompson PM, Buitelaar JK, Franke B. Consortium neuroscience of attention deficit/hyperactivity disorder and autism spectrum disorder: The ENIGMA adventure. Hum Brain Mapp. 2020 May 18. doi: 10.1002/hbm.25029.
Walhovd KB, Amlien I, Schrantee A, Rohani DA, Groote I, Bjørnerud A, Fjell AM, Reneman L. Methylphenidate Effects on Cortical Thickness in Children and Adults with Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial. AJNR Am J Neuroradiol. 2020 May;41(5):758-765. doi: 10.3174/ajnr.A6560. PMID: 32414901
Solleveld MM, Schrantee A, Baek HK, Bottelier MA, Tamminga HGH, Bouziane C, Stoffelsen R, Lucassen PJ, Van Someren EJW, Rijsman RM, Reneman L. Effects of 16 Weeks of Methylphenidate Treatment on Actigraph-Assessed Sleep Measures in Medication-Naive Children With ADHD. Front Psychiatry. 2020 Feb 28;11:82. doi: 10.3389/fpsyt.2020.00082. eCollection 2020.
Schrantee A, Ruhé HG, Reneman L. Psychoradiological Biomarkers for Psychopharmaceutical Effects. Neuroimaging Clin N Am. 2020 Feb;30(1):53-63. doi: 10.1016/j.nic.2019.09.006.
Karel P, Van der Toorn A, Vanderschuren L, Guo C, Sadighi Alvandi M, Reneman L, Dijkhuizen R, Verheij MMM, Homberg JR. 2020. Ultrahigh-resolution MRI reveals structural brain differences in serotonin transporter knockout rats after sucrose and cocaine self-administration. Addict Biol. 2020 Jan;25(1):e12722. doi: 10.1111/adb.12722.
Chye Y, Mackey S, Gutman BA, Ching CRK, Batalla A, Blaine S, Brooks S, Caparelli EC, Cousijn J, Dagher A, Foxe JJ, Goudriaan AE, Hester R, Hutchison K, Jahanshad N, Kaag AM, Korucuoglu O, Li CR, London ED, Lorenzetti V, Luijten M, Martin-Santos R, Meda SA, Momenan R, Morales A, Orr C, Paulus MP, Pearlson G, Reneman L, Schmaal L, Sinha R, Solowij N, Stein DJ, Stein EA, Tang D, Uhlmann A, van Holst R, Veltman DJ, Verdejo-Garcia A, Wiers RW, Yücel M, Thompson PM, Conrod P, Garavan H. Subcortical surface morphometry in substance dependence: An ENIGMA addiction working group study. Addict Biol. 2019 Nov 20:e12830. doi: 10.1111/adb.12830.
Bouziane C, Filatova OG, Schrantee A, Caan MWA, Vos FM, Reneman L. 2019. White Matter by Diffusion MRI Following Methylphenidate Treatment: A Randomized Control Trial in Males with Attention-Deficit/Hyperactivity Disorder. Radiology (in press, doi: 10.1148/radiol.2019182528).
de Kovel CGF, Aftanas L, Aleman A, Alexander-Bloch AF, Baune BT, Brack I, Bülow R, Busatto Filho G, Carballedo A, Connolly CG, Cullen KR, Dannlowski U, Davey CG, Dima D, Dohm K, Erwin-Grabner T, Frodl T, Fu CHY, Hall GB, Glahn DC, Godlewska B, Gotlib IH, Goya-Maldonado R, Grabe HJ, Groenewold NA, Grotegerd D, Gruber O, Harris MA, Harrison BJ, Hatton SN, Hickie IB, Ho TC, Jahanshad N, Kircher T, Krämer B, Krug A, Lagopoulos J, Leehr EJ, Li M, MacMaster FP, MacQueen G, McIntosh AM, McLellan Q, Medland SE, Mueller BA, Nenadic I, Osipov E, Papmeyer
M, Portella MJ, Reneman L, Rosa PGP, Sacchet MD, Schnell K, Schrantee A, Sim K, Simulionyte E, Sindermann L, Singh A, Stein DJ, Ubani BN, Van der Wee NJA, Van der Werff SJA, Veer IM, Vives-Gilabert Y, Völzke H, Walter H, Walter M, Schreiner MW, Whalley H, Winter N, Wittfeld K, Yang TT, Yüksel D, Zaremba D, Thompson PM, Veltman DJ, Schmaal L, Francks C. 2019. No Alterations of Brain Structural Asymmetry in Major Depressive Disorder: An ENIGMA Consortium Analysis. Am J Psychiatry (in press, appiajp201918101144).
Vingerhoets C, Bakker G, Schrantee A, van der Pluijm M, Bloemen OJN, Reneman L, Caan M, Booij J, van Amelsvoort TAMJ. 2019. Influence of muscarinic M(1) receptor antagonism on brain choline levels and functional connectivity in medication-free subjects with psychosis: A placebo controlled, cross-over study. Psychiatry Res Neuroimaging 30;290:5-13.
Hoogman M, Muetzel R, Guimaraes JP, Shumskaya E, Mennes M, Zwiers MP, Jahanshad N, Sudre G, Wolfers T, Earl EA, Soliva Vila JC, Vives-Gilabert Y, Khadka S, Novotny SE, Hartman CA, Heslenfeld DJ, Schweren LJS, Ambrosino S, Oranje B, de Zeeuw P, Chaim-Avancini TM, Rosa PGP, Zanetti MV, Malpas CB, Kohls G, von Polier GG, Seitz J, Biederman J, Doyle AE, Dale AM, van Erp TGM, Epstein JN, Jernigan TL, Baur-Streubel R, Ziegler GC, Zierhut KC, Schrantee A, Høvik MF, Lundervold AJ, Kelly C, McCarthy H, Skokauskas N, O’Gorman Tuura RL, Calvo A,
Lera-Miguel S, Nicolau R, Chantiluke KC, Christakou A, Vance A, Cercignani M, Gabel MC, Asherson P, Baumeister S, Brandeis D, Hohmann S, Bramati IE, Tovar-Moll F, Fallgatter AJ, Kardatzki B, Schwarz L, Anikin A, Baranov A, Gogberashvili T, Kapilushniy D, Solovieva A, El Marroun H, White T, Karkashadze G, Namazova-Baranova L, Ethofer T, Mattos P, Banaschewski T, Coghill D, Plessen KJ, Kuntsi J, Mehta MA, Paloyelis Y, Harrison NA, Bellgrove MA, Silk TJ, Cubillo AI, Rubia K, Lazaro L, Brem S, Walitza S, Frodl T, Zentis M, Castellanos FX, Yoncheva YN, Haavik J, Reneman L, Conzelmann A, Lesch KP, Pauli P, Reif A, Tamm L, Konrad K, Oberwelland Weiss E, Busatto GF, Louza MR, Durston S, Hoekstra PJ, Oosterlaan J, Stevens MC, Ramos-Quiroga JA, Vilarroya O, Fair DA, Nigg JT, Thompson PM, Buitelaar JK, Faraone SV, Shaw P, Tiemeier H, Bralten J, Franke B. 2019. Brain Imaging of the Cortex in ADHD: A Coordinated Analysis of Large-Scale Clinical and Population-Based Samples. Am J Psychiatry 176(7):531-542.
Schrantee A, Solleveld MM, Schwantje H, Bruin WB, Mutsaerts HM, Adriaanse SM, Lucassen P, Booij J, Reneman L. 2019. Dose-dependent effects of the selective serotonin reuptake inhibitor citalopram: A combined SPECT and phMRI study. J Psychopharmacol 33(6):660-669.
Karel P, Van der Toorn A, Vanderschuren L, Guo C, Sadighi Alvandi M, Reneman L, Dijkhuizen R, Verheij MMM, Homberg JR. 2019. Ultrahigh-resolution MRI reveals structural brain differences in serotonin transporter knockout rats after sucrose and cocaine self-administration. Addict Biol. (n press doi: 10.1111/adb.12722).
Lønning K, Putzky P, Sonke JJ, Reneman L, Caan MWA, Welling M. R2019. 2019 Recurrent inference machines for reconstructing heterogeneous MRI data. Med Image Anal. 53:64-78.
Karel P, Almacellas-Barb anoj A, Prijn J, Kaag AM, Reneman L, Verheij MMM,Homberg JR. 2019. Appetitive to aversive counter-conditioning as intervention to reducereinstatement of reward-seeking behavior: the role of the serotonin transporter. Addict Biol; 24(3):344-354.
Kaag AM, Schulte MHJ, Jansen JM, van Wingen G, Homberg J, van den Brink W, Wiers RW, Schmaal L, Goudriaan AE, Reneman L. 2018 The relation between gray matter volume and the use of alcohol, tobacco, cocaine and cannabis in male polysubstance users. Drug Alcohol Depend. 187:186-194.
Stouten-Kemperman MM, de Ruiter MB, Boogerd W, Kerst JM, Kirschbaum C, Reneman L, Schagen SB. 2018 Brain Hyperconnectivity >10 Years After Cisplatin-Based Chemotherapy for Testicular Cancer. Brain Connect 8(7):398-406.
Schrantee A, Lucassen PJ, Booij J, Reneman L. 2018. Serotonin transporter occupancy by the SSRI citalopram predicts default-mode network connectivity. Eur Neuropsychopharmacol 28(10):1173-1179. .
Kaag AM, Reneman L, Homberg J, van den Brink W, van Wingen GA. 2018. Enhanced Amygdala -Striatal Functional Connectivity during the Processing of Cocaine Cuesin Male Cocaine Users with a History of Childhood Trauma. Front Psychiatry. 12: 9:70.
van Iersel L, Meijneke RWH, Schouten-van Meeteren AYN, Reneman L, de Win MM, van Trotsenburg ASP, Bisschop PH, Finken MJJ, Vandertop WP, van Furth WR, vanSanten HM. 2018. The development of hypothalamic obesity in craniopharyngioma patients:A risk factor analysis in a well-defined cohort. Pediatr Blood Cancer 2018; 65(5):e26911.
Mugie SM, Koppen IJN, van den Berg MM, Groot PFC, Reneman L, de Ruiter MB,Benninga MA. 2018. Brain processing of rectal sensation in adolescents with functional defecation disorders and healthy controls. Neurogastroenterol Motil (in press).
Schrantee A, Bouziane C, Bron EE, Klein S, Bottelier MA, Kooij JJ, Rombouts SA, Reneman L. 2018. Long-term effects of stimulant exposure on cerebral blood flow response to methylphenidate and behavior in attention-deficit hyperactivity disorder. Brain Imaging Behav 12(2):402-410.
Bouziane C, Caan MWA, Tamminga HGH, Schrantee A, Bottelier MA, de Ruiter MB,Kooij SJJ, Reneman L. 2017. ADHD and maturation of brain white matter: A DTI study inmedication naive children and adults. Neuroimage Clin. 29: 53-59.
Bottelier MA, Schrantee A, Ferguson B, Tamminga HGH, Bouziane C, Kooij JJS, de Ruiter MB, Reneman L. 2017. Age-dependent effects of acute methylphenidate on amygdala reactivity in stimulant treatment-naive patients with Attention Deficit/Hyperactivity Disorder. Psychiatry Res. 269: 36-42.
Staphorst MS, Benninga MA, Bisschoff M, Bon I, Busschbach JJV, Diederen K, van Goudoever JB, Haarman EG, Hunfeld JAM, Jaddoe VVW, de Jong KJM, de Jongste JC, Kindermann A, Königs M, Oosterlaan J, Passchier J, Pijnenburg MW, Reneman L, Ridder L, Tamminga HG, Tiemeier HW, Timman R, van de Vathorst S. 2017. The child’s
perspective on discomfort during medical research procedures: a descriptive study. BMJ Open. 7: e016077.
Schulte MHJ, Kaag AM, Wiers RW, Schmaal L, van den Brink W, Reneman L, Homberg JR, van Wingen GA, Goudriaan AE. 2017. Prefrontal Glx and GABA concentrations and impulsivity in cigarette smokers and smoking polysubstance users. Drug Alcohol Depend. 179:117-123.
Huffnagel IC, Redeker EJW, Reneman L, Vaz FM, Ferdinandusse S, Poll-The BT. 2017. Mitochondrial Encephalopathy and Transient 3-Methylglutaconic Aciduria in ECHS1 Deficiency: Long-Term Follow-Up. JIMD Rep (in press).
Solleveld MM, Schrantee A, Puts NAJ, Lucassen PJ, * Reneman L*. 2017. Age-dependent, lasting effects of methylphenidate on the GABAergic system of ADHD patients. Neuroimage Clin. 5: 812-818. *These authors contributed equally
Schrantee A, Václavů L, Reneman L, Verberne HJ, Booij J, Tan HL. 2017 QT prolongation by dexamphetamine: Does experience matter? J Cardiovasc Electrophysiol. 28: 912-916.
Versteeg RI, Schrantee A, Adriaanse SM, Unmehopa UA, Booij J, Reneman L, Fliers E, la Fleur SE, Serlie MJ. 2017. Timing of caloric intake during weight loss differentially affects striatal dopamine transporter and thalamic serotonin transporter binding. FASEB J 31: 4545-4554.
Menning S, de Ruiter MB, Veltman DJ, Boogerd W, Oldenburg HS, Reneman L, Schagen SB. 2017. Changes in brain white matter integrity after systemic treatment for breast cancer: a prospective longitudinal study. Brain Imaging Behav (in press).
Menning S, de Ruiter MB, Veltman DJ, Boogerd W, Oldenburg HS, Reneman L, Schagen SB. 2017. Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type. PLoS One. 12: e0171724.
Schrantee A, Tremoleda JL, Wylezinska-Arridge M, Bouet V, Hesseling P, Meerhoff GF, de Bruin KM, Koeleman J, Freret T, Boulouard M, Desfosses E, Galineau L, Gozzi A, Dauphin F, Gsell W, Booij J, Lucassen PJ, Reneman L. 2017.
Repeated dexamphetamine treatment alters the dopaminergic system and increases the phMRI response to methylphenidate. PLoS One 12: e0172776.
van Dijk T, Barth P, Reneman L, Appelhof B, Baas F, Poll-The BT. 2017.A de novo missense mutation in the inositol 1,4,5-triphosphate receptor type 1 gene causing severe pontine and cerebellar hypoplasia: Expanding the phenotype of ITPR1-related spinocerebellar ataxia’s. Am J Med Genet A. 173: 207-212.
Karel P, Calabrese F, Riva M, Brivio P, Van der Veen B, Reneman L, Verheij M, Homberg J. 2018. d-Cycloserine enhanced extinction of cocaine-induced conditioned place preference is attenuated in serotonin transporter knockout rats. Addict Biol. 23:120-129.
Schrantee A, Mutsaerts H, Bouziane C, Tamminga H, Bottelier MA, Reneman L. 2016. The age-dependent effects of a single-dose methylphenidate challenge on cerebral perfusion in patients with attention-deficit/hyperactivity disorder. Neuroimage Clin. 13:123-129.
Menning S, de Ruiter MB, Kieffer JM, Agelink van Rentergem J, Veltman DJ, Fruijtier A, Oldenburg HS, Boven E, van der Meij S, Lustig V, Bos ME, Boogerd W, Reneman L, Schagen SB. 2016. Cognitive Impairment in a Subset of Breast Cancer Patients After Systemic Therapy-Results From a Longitudinal Study. J Pain Symptom Manage. 52:560-569.e1
Vegting Y, Reneman L, Booij J. 2016. The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies. Psychopharmacology 233: 3473-3501.
Kaag AM, Schluter RS, Karel P, Homberg J, van den Brink W, Reneman L, van Wingen GA. 2016. Aversive Counterconditioning Attenuates Reward Signaling in the Ventral Striatum. Front Hum Neurosci.10: 418.
Bottelier MA, Schrantee A, van Wingen G, Ruhé HG, de Ruiter MB, Reneman L. 2016. A power analysis for future clinical trials on the potential adverse effects of SSRIs on amygadala reactivity. Front Bio 3: 256-259.
Kaag AM, van Wingen GA, Caan MW, Homberg JR, van den Brink W, Reneman L. 2016. White matter alterations in cocaine users are negatively related to the number of additionally (ab)used substances. Addict Biol 22: 1048-1056.
Schrantee A, Tamminga,HGH, Bouziane C, Bottelier MA, Bron EE, Mutsaerts HJMM, Zwinderman AH, Groote IR, Rombouts SARB, Lindauer RJL, Klein S, Niessen WJ, Opmeer BC, Boer F, Lucassen PJ, Andersen SL, Geurts HM, Reneman L. Age-Dependent Effects of Methylphenidate on the Human Dopaminergic System in Young vs Adult Patients With Attention-Deficit/Hyperactivity Disorder, JAMA Psychiatry 73: 955-962.
van de Vijver I, Ridderinkhof KR, Harsay H, Reneman L, Cavanagh JF, Buitenweg JIV, Cohen MX. Frontostriatal anatomical connections predict reinforcement learning success with increasing task difficulty and age. Neurobiol Aging 46: 1-12.
Tamminga HG, Reneman L, Huizenga HM, Geurts HM. 2016. Effects of methylphenidate on executive functioning in attention-deficit/hyperactivity disorder across the lifespan: a meta-regression analysis. Psychol Med 46:1791-807.
Su T, Wit FW, Caan MW, Schouten J, Prins M, Geurtsen GJ, Cole JH, Sharp DJ, Richard E, Reneman L, Portegies P, Reiss P, Majoie CB; AGEhIV Cohort Study. 2016. White matter hyperintensities in relation to cognition in HIV-infected men with sustained suppressed viral load on cART. AIDS 30: 2329-2339.
Kaag AM, Levar N, Woutersen K, Homberg J, van den Brink W, Reneman L, van Wingen G. 2016. Hyperresponsiveness of the Neural Fear Network During Fear Conditioning and Extinction Learning in Male Cocaine Users. Am J Psychiatry 173: 1033-1042.
van Doorn MMAC, Oude Rengerink K, Newsum EA, Reneman L, Majoie CBLM, Pajkrt E. 2016. Added value of fetal MRI in fetuses with suspected brain abnormalities on neurosonography: a systematic review and meta-analysis. The Journal of Maternal-Fetal & Neonatal Medicine 29:2949-2961.
Schrantee AGM, Ferguson B, Stoffers D, Booij J, Rombouts SERB, Reneman L. 2016. Effects of dexamphetamine-induced dopamine release on resting-state network connectivity in chronic dexamphetamine users and controls. Brain Imaging and Behavior 10: 548-558.
Tamminga HGH, Reneman L, Huizenga HM, Geurts HM. Effects of methylphenidate on executive functioning in ADHD across the lifespan: A meta-regression analysis. 2015. Psychological Medicine. Journal of Abnormal Child Psychology 46:1791-1807.
van der Marel, Bouet V, Meerhoff G, Freret T, Boulouard M, Dauphin F, Klomp A, Lucassen PJ, Homberg JR, Dijkhuizen RM*, Reneman L*. 2015. Effects of long-term methylphenidate treatment in adolescent and adult rats on hippocampal shape, functional connectivity and adult neurogenesis. Neuroscience 19: 243-258.
*These authors contributed equally
Stouten-Kemperman M, de Ruiter MB, Caan MWA, Boogerd W, Kerst J, Reneman L, Schagen S. 2015. Lower cognitive performance and white matter changes in testicular cancer survivors 10 years after chemotherapy. Human Brain Mapping 36: 4638-4647.
Crunelle CL, Kaag AM, van den Munkhof HE, Reneman L, Homberg JR, Sabbe B, van den Brink W, van Wingen G. 2015. Dysfunctional amygdala activation and connectivity with the prefrontal cortex in current cocaine users. Hum Brain Mapping 36: 4222-4230.
Reneman L, Schagen SB, Mulder M, Mutsaerts HJ, Hageman G, de Ruiter MB. 2015. Cognitive impairment and associated loss in brain white microstructure in aircrew members exposed to engine oil fumes. Brain Imaging and Behavior 10: 437-444.
Bottelier MA, Schouw MLJ, de Ruiter MB, Ruhe HG, Lindauer RJL, Reneman L. 2015. Effects of methylphenidate during emotional processing in amphetamine users: preliminary findings. Brain Imaging and Behavior 9: 878-886.
Stouten-Kemperman MM, de Ruiter MB, Boogerd W, Veltman DJ, Reneman L, Schagen SB. 2015. Very late treatment-related alterations in brain function of breast cancer survivors. Journal of the International Neuropsychological Society 21: 50-61.
Menning S, de Ruiter MB, Veltman DJ, Kirschbaum C, Boogerd W, Reneman L, Schagen S. 2015. Multimodal MRI and cognitive function in patients with breast cancer prior to adjuvant treatment – The role of fatigue. Neuroimage Clinical 20: 547-554.
Van Schaik SM, Reneman L, Engelen M, Roos YB, Poll-The BT. 2015. Strokelike Episodes and Cutis Marmorata Telangiectatica Congenita. J Child Neurol 30:129-32.
Schrantee A, Vaclavu L, Heijtel DFR, Caan MWA, Gsell W, Lucassen PJ, Nederveen AJ, Booij J, Reneman L. 2015. Dopaminergic system dysfunction in recreational dexamphetamine users. Neuropsychopharmacology 13: 1172-1180
Stouten-Kemperman MM, de Ruiter MB, Koppelmans V, Boogerd W, Reneman L, Schagen SB. 2015. Neurotoxicity in in breast cancer survivors > 10 years post-treatment is dependent on treatment type. Brain Imaging and Behavior 9: 275-284.
Kaag AM, Crunelle CL, van Wingen G, Homberg J, van den Brink W, Reneman L. 2014. Relationship between trait impulsivity and cortical volume, thickness and surface area in male cocaine users and non-drug using controls. Drug and Alcohol Dependence 144:210-7.
Klomp A, Hamelink R, Feenstra M, Denys D, Reneman L. 2014. Increased Response to a 5-HT Challenge After Discontinuation of Chronic Serotonin Uptake Inhibition in the Adult and Adolescent Rat Brain. PLoS One 17: 9: e99873.
Klomp A, Vaclavu L, Meerhoff GF, Reneman L, Lucassen PJ. 2014. Effects of chronic fluoxetine treatment on neurogenesis and tryptophan hydroxylase expression in adolescent and adult rats. PLoS One 14: 9:e97603.
Schiering IA, de Haan TR, Niermeijer JM, Koelman JH, Majoie CB, Reneman L, Aronica E. 2014. Correlation between clinical and histologic findings in the human neonatal hippocampus after perinatal asphyxia. J Neuropathol Exp Neurol 73:324-34.
Bottelier MA, Schouw ML, Klomp A, Tamminga HG, Schrantee AG, Bouziane C, de Ruiter MB, Boer F, Ruhé HG, Denys D, Rijsman R, Lindauer RJ, Reitsma HB, Geurts HM, Reneman L. 2014. The effects of Psychotropic drugs On Developing brain (ePOD) study: methods and design. BMC Psychiatry 19;14:48.
Crunelle CL, Kaag AM, van Wingen G, van den Munkhof HE, Homberg JR, Reneman L, van den Brink W. 2014. Reduced frontal brain volume in non-treatment-seekingcocaine-dependent individuals: exploring the role of impulsivity, depression, and smoking. Front Hum Neurosci 17; 8:7.
van der Marel K, Klomp A, Meerhoff GF, Schipper P, Lucassen PJ, Homberg JR, Dijkhuizen RM, Reneman L. 2014. Long-term oral methylphenidate treatment in adolescent and adult rats: differential effects on brain morphology and function.Neuropsychopharmacology 39:263-73.
Schrantee A, Reneman L. 2014. Pharmacological imaging as a tool to visualize dopaminergic neurotoxicity. Neuropharmacology 84C:159-169.
van Arnhem LA, Bunders MJ, Scherpbier HJ, Majoie CB, Reneman L, Frinking O, Poll-The BT, Kuijpers TW, Pajkrt D. 2013. Neurologic abnormalities in HIV-1 infected children in the era of combination antiretroviral therapy. PLoS One 8:e64398.
Klomp A, van Wingen GA, de Ruiter MB, Caan MW, Denys D, Reneman L. 2013. Test-retest reliability of task-related pharmacological MRI with a single-dose oral citalopram challenge. Neuroimage. 75:108-16.
Schouw ML, Caan MWA, Geurts HM, Schmand B, Booij J, Nederveen AJ, Reneman L. 2013. Monoaminergic dysfunction in recreational users of dexamphetamine. European Neuropsychopharmacology 3:1491-502.
Schouw ML, de Ruiter MB, Kaag AM, van den Brink W, Lindauer RJ, Reneman L. 2013. Dopaminergic dysfunction in abstinent dexamphetamine users: results from a pharmacological fMRI study using a reward anticipation task and a methylphenidate challenge. Drug Alcohol Depend 130:52-60.
Schouw ML, Kaag AM, Caan MW, Heijtel DF, Majoie CB, Nederveen AJ, Booij J, Reneman L. 2013. Mapping the hemodynamic response in human subjects to a dopaminergic challenge with dextroamphetamine using ASL-based pharmacological MRI. Neuroimage 72:1-9.
van Wezel EM, van Santen HM, van Furth WR, Reneman L, Bisschop PH, van Trotsenburg AS. 2012. [Children with obesity and declining linear growth curve: Cushing’s disease. Ned Tijdschr Geneeskd 156:A4677.
Booij, J, Reneman L, Alders M, Kuijpers TW. 2013. Increase in central striatal dopamine transporters in patients with Shwachman-Diamond syndrome: additional evidence of a brain phenotype. Am J Med Genet A 2013;161:102-7.
Klomp A, Caan MW, Denys D, Nederveen AJ, Reneman L. 2012. Feasibility of ASL-based phMRI with a single dose of oral citalopram for repeated assessment of serotonin function. Neuroimage 63:1695-700.
Klomp A, den Hollander B, de Bruin CM, Booij J, Reneman L. 2012. The effects of ecstasy (MDMA) on brain serotonin transporters are dependent on age-of-first exposure in recreational users and animals. Plos One 7:e47524.
den Hollander B, Schouw M, Groot P, Huisman H, Caan M, Barkhof F, Reneman L. 2012. Preliminary evidence of hippocampal damage in chronic users of ecstasy. J Neurol Neurosurg Psychiatry 83:83-5.
Klomp A, Tremoleda JL, Wylezinska M, Nederveen AJ, Feenstra M, Gsell W, Reneman L. 2012. Lasting effects of chronic fluoxetine treatment on the late developing rat brain: age-dependent changes in the serotonergic neurotransmitter system assessed by pharmacological MRI. Neuroimage 59:218-26.
Reneman L, de Win MM, Booij J, van den Brink W, den Heeten GJ, C.B.L.M. Majoie. 2012. Incidental brain findings on MRI in young healthy volunteers: prevalence and clinical implications. AJNR Am J Neuroradiol. 33:1971-4.
de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, Caan M, Douaud G, Lavini C, Linn SC, Boven E, van Dam FS, Schagen SB. 2012. Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging. Hum Brain Mapp 33:2971-83.
Schouw M, Schagen S, Caan M, Majoie CBLM, Booij J, Nederveen AJ, Reneman L. 2012. Mapping serotonergic dysfunction in MDMA (ecstasy) users using Pharmacological Magnetic Resonance Imaging. Eur Neuropsychopharmacol 22:537-45.
Bouet V, Klomp A, Freret T, Wylezinska M, Tremoleda J, Dauphin F, Boulouard M, Jan Booij J, Gsell W, Reneman L. 2012. Chronic fluoxetine treatment affects outgrowth and functionality of the serotonergic system, but not behavior, in an age-dependent manner. Psychopharmacology 221:329-39.
Klomp A, Tremoleda JL, Schrantee A, Gsell W, Reneman L. 2012. The use of pharmacological-challenge fMRI in pre-clinical research: application to the 5-HT system. J Vis Exp. 25. Video link
Harsay HA, Cohen MX, Reneman L, Ridderinkhof KR. 2011. How the aging brain translates motivational incentive into action: the role of individual differences in striato-cortical white matter pathways. Dev Cogn Neurosci 1:530-9.
Homberg JR, Olivier JD, Blom T, Arentsen T, van Brunschot C, Schipper P, Korte-Bouws G, van Luijtelaar G, Reneman L. 2011. Fluoxetine exerts age-dependent effects on behavior and amygdala neuroplasticity in the rat. PLoS One 31: 6, e16646.
de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, van Dam FSAM, Nederveen AJ, Boven E, Schagen S. 2011. Cerebral hyporesponsiveness and cognitive impairment ten years after chemotherapy for breast cancer. Human Brain Mapping 32: 1206-1219.
de Win MM, Jager G, Booij J, Reneman L, Schilt T, Lavini C, Olabarriaga SD, den Heeten GJ, van den Brink W. 2008. Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users. Brain 131: 2936-2945.
de Win MM, Jager G, Booij J, Reneman L, Schilt T, Lavini C, Olabarriaga SD, Ramsey NF, Heeten GJ, van den Brink W. 2008. Neurotoxic effects of ecstasy on the thalamus. Br J Psychiatry 193: 289-296.
Visser I, Lavini C, Booij J, Reneman L, Majoie CBLM, de Boer A, Wekking EM, de Joode EA, van der Laan G, van Dijk FJH, Schene AH, den Heeten GJ. 2008. Frontostriatothalamic impairment in chronic solvent-induced encephalopathy. Ann Neurology 63:572-580.
de Win MML, Reneman L, Jager G, Vlieger EJP, Olabarriaga SD, Lavini C, Bisschops I, Majoie CBLM, Booij J, van den Brink W, den Heeten GJ. 2007. A prospective cohort study on non-acute effects of low dose ecstasy use on the brain in new ecstasy users. Neuropsychopharmacology 32: 458-470.
Reneman L, de Win MM, van den Brink W, Booij J, den Heeten GJ. 2006. Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects. J Psychopharmacol 20: 164-175.
Reneman L, Schilt T, de Win MM, Booij J, van den Brink W, Bakker O. 2006. Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users. J Psychopharmacology 20: 389-399.
de Win MM, Schilt T, Reneman L, Vervaeke HK, Jager G, Dijkink S, Booij, J, van den Brink W. 2006. Ecstasy use and self-reported depression, impulsivity and sensation-seeking: a prospective cohort study. J Psycopharmacology 20: 226-235.
de Win MM, Jager G, Vervaeke HK, Schilt T, Reneman L, Booij J, Verhulst FC, Den Heeten GJ, Ramsey NF, Korf DJ, Van den Brink W. 2005. The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance. Int J Methods Psychiatr Res 14: 167-185.
de Win MM, Habraken JB, Reneman L, van den Brink W, den Heeten GJ, Booij J. 2005. Validation of [(123)I]beta-CIT SPECT to Assess Serotonin Transporters In Vivo in Humans: a Double-Blind, Placebo-Controlled, Crossover Study with the Selective Serotonin Reuptake Inhibitor Citalopram. Neuropsychopharmacology 30: 996-1005.
de Win MM, de Jeu RA, de Bruin K, Habraken JB, Reneman L, Booij J, den Heeten GJ. Validity of in vivo [123I]beta-CIT SPECT in detecting MDMA-induced neurotoxicity in rats. Eur Neuropsychopharmacol 14: 185-189.
de Win MM, Reneman L, Reitsma JB, den Heeten GJ, Booij J, van den Brink W. Mood disorders and serotonin transporter density in ecstasy users–the influence of long-term abstention, dose, and gender. Psychopharmacology 173: 376-82.
Reneman L. 2003. Designer drugs: How safe are they ? J Neural Transm (S); 66: 61-83.
Van den Brink W, Reneman L, Booij J, Majoie CBLM, den Heeten GJ. 2003. Ecstasy will it contribute to co-morbidity. Addiction Biology 8: 233-250.
Reneman L, Booij J, Heeten, GJ, and van Den Brink W. 2002. Effects of MDMA (ecstasy) use and abstention on serotonin neurons (letter). Lancet 359: 1617-1618.
Reneman L, Booij J, Habraken JB, De Bruin K, Hatzidimitriou G, Den Heeten GJ, Ricaurte GA. 2002. Validity of [123I]beta-CIT SPECT in detecting MDMA-induced serotonergic neurotoxicity. Synapse 46:199-205.
Hurley A, Reneman L, Ricaurte GA, Taber K. 2002. Ecstasy in the Brain: A Model for Imaging the Serotonin System. J Neuropsychiatry Clin Neurosci 14: 125-129.
Reneman L, Endert E, de Bruin K, Lavalaye J, Feenstra MG, de Wolff FA, Booij J. 2002. The acute and chronic effects of MDMA (“Ecstasy”) on cortical 5-HT2A receptors in rat and human brain. Neuropsychopharmacology 26: 387-396.
Reneman L, Booij J, Lavalaye J, de Bruin K, Reitsma JB, Gunning WB, den Heeten GJ, van den Brink W. 2002. Use of amphetamine by recreational users of ecstasy is associated with reduced striatal dopamine transporter densities: a [123I]-CIT SPECT study. Psychopharmacology 159: 335-340.
Reneman L, Booij J, de Bruin K, de Wolff FA, Gunning WB, den Heeten GJ, vd Brink W. 2001. Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet 358: 1864-1869.
Reneman L, Booij J, Majoie CBLM, van den Brink W, den Heeten GJ. 2001. The potential neurotoxicity of MDMA: an imaging approach. Hum Psychopharmacol Clin Exp 16: 579-588.
Reneman L, Lavalaye J, Booij J, Schmand B, de Wolff FA, vd Brink W, den Heeten GJ, Booij J. 2001. Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethaphetamine (MDMA or “Ecstasy”) – Preliminary findings. Arch Gen Psychiatry 58: 901-906.
Reneman L, Majoie CBLM, Schmand B, vd Brink W, den Heeten GJ. 2001. Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) Ecstasy users: Preliminary report. Biol Psychiatry 50: 550-554.
Reneman L, Majoie CBLM, Habraken JBA, den Heeten GJ. 2001. Effects of Ecstasy (MDMA) on the brain in abstinent users: Initial observations with diffusion and perfusion MR imaging. Radiology 220: 611-617.
Reneman L, de Bruin K, Lavalaye J, Gunning WB, Booij J. 2001. Addition of a 5-HT receptor agonist to methylphenidate potentiates the reduction of [123I]FP-CIT binding to dopamine transporters in rat frontal cortex and hippocampus. Synapse 39: 193-200.
Lavalaye J, Sarlet A, Booij J, Linszen DH, Reneman L, Gersons BP, van Royen EA. 2001. Dopamine transporter density in patients with tardive dyskinesia: a single photon emission computed tomography study. Psychopharmacology 155:107-109.
Lavalaye J, Linszen DH, Booij J, Dingemans PM, Reneman L, Habraken JB, Gersons BP, van Royen EA. 2001. Dopamine transporter density in young patients with schizophrenia assessed with [123I]FP-CIT SPECT. Schizophr Res 47:59-67.
Lavalaye J, Booij J, Linszen DH, Reneman L, van Royen EA. 2001. Higher occupancy of muscarinic receptors by olanzapine than risperidone in patients with schizophrenia. A[123I]-IDEX SPECT study. Psychopharmacology 156:53-7.
Reneman L, Habraken J, Majoie CBL, Booij J, den Heeten GJ. 2000. MDMA (“Ecstasy”) and its predisposition to cerebrovascular accidents – Preliminary findings. AJNR Am J Neuroradiol 21:1001-7.
Reneman L, Booij J, Schmand B, vd Brink W, Gunning WB. 2000. Memory disturbances in “Ecstasy” (MDMA) users are correlated with an altered brain serotonin neurotransmission. Psychopharmacology 148: 322-324.
Lavalaye J, Booij J, Reneman L, Habraken JB, van Royen EA. 2000. Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers. Eur J Nucl Med 27:867-869.
Lavalaye J, Knol RJ, de Bruin K, Reneman L, Janssen AG, Booij J. 2000. [123I]FP-CIT binding in rat brain after acute and sub-chronic administration of dopaminergic medication. Eur J Nucl Med 27: 346-349.
Reneman L, Booij J, Lavalaye J, de Bruin K, Stoof JC, de Wolff FA, Koopmans RP, den Heeten GJ. 1999. A comparative in vivo study of iodine-123 labelled -CIT and iodine 123 labelled nor–CIT to serotonin transporters in rat brain. Synapse 34: 77-80.
Lavalaye J, Linszen DH, Booij J, Reneman L, Gersons BP, van Royen EA. 1999. Dopamine D2 receptor occupancy by olanzapine or risperidone in young patients with schizophrenia. Psychiatry Res 92: 33-44.
Booij J, Knol RCC, Reneman L, de Bruin K, van Royen EA. 1998. Iodine-123 labelled nor-CIT binds to the serotonin transporter in vivo as assessed by biodistribution studies in rats. Eur J Nucl Med 25: 1666-1669.
Reneman L, Derwig J. 1997. Long-term prospects of malnourished children after rehabilitation at the Nutrition Rehabilitation Centre of St Mary’s Hospital, Mumias, Kenya. J Trop Pediatr 43: 293-296.
